Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SenPET: [18F]FPyGal PET Imaging for Tumor Senescence
NCT04536454Phase 2Unknown
- Sponsor
- University Hospital Tübingen
- Start
- Apr 2021
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of [18F]FPyGal in cancer, sponsored by University Hospital Tübingen. Status: unknown.
02
Drugs
[18F]FPyGal
03
Conditions
cancer
Beyond the preview
Go deeper on NCT04536454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04536454.